Immedica ranked Top 2 among Sweden's Best Workplaces™ 2025

Stockholm, April 25 , 2025 – Immedica has earned a Top 2 ranking among Sweden’s Best Workplaces™ 2025, awarded by Great Place to Work®. This prestigious award is based on the world’s largest employee survey, where organizations are evaluated and ranked according to their employees’ experiences, particularly in areas such as leadership and trust. In this year’s ranking, presented at a gala in Stockholm on April 24, Immedica was ranked two in the category of medium sized organizations with 50-249 employees.

“Being named Top 2 of Sweden’s Best Workplaces is a testament to our efforts in creating an environment where people thrive, grow, and feel included. We are extremely proud of our company, which is made up of dedicated employees who contribute every day to building a strong and positive atmosphere for each other and in the end for the patients we serve,” says Anders Edvell, CEO

Recognition based on employee experience
Sweden’s Best Workplaces™ is an award presented by Great Place to Work®, the global leader in workplace culture analysis and development. The ranking is based on their annual employee survey, where employees share their experiences of the workplace culture. Key criteria include leadership, fairness, respect, credibility, pride, and camaraderie. Out of thousands of organizations surveyed, only 65 are named among Sweden’s Best Workplaces™.

“Immedica has demonstrated that they are one of Sweden’s top workplaces through their long-term commitment to building trust and fostering a sense of belonging. They are a role model in their industry, and we are proud to highlight them as one of the absolute best workplaces,” says Jeanette Bergvall, CEO of Great Place to Work®.

About Sweden’s Best Workplaces™
Sweden’s Best Workplaces™ 2025 lists the top 65 organizations in Sweden that excel at creating a positive, sustainable, and healthy workplace culture for all employees. The ranking is based on Great Place to Work®’s annual employee survey, backed by 40 years of expertise in workplace culture analysis across more than 170 countries. The results reflect employees’ own experiences and assess factors that drive well-being, innovation, and long-term success. The ranking of Sweden’s Best Workplaces™ has been published annually since 2003, making this the 23rd edition.

About Immedica
Immedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Immedica’s capabilities cover marketing and sales, compliance, pharmacovigilance, quality assurance, regulatory, medical affairs and market access, as well as a global distribution network serving patients in more than 50 countries. Immedica is fully dedicated to helping those living with diseases which have a large unmet medical need. Immedica’s therapeutic areas are within RARE metabolic, RARE hematology & oncology, RARE neurology and specialty care. Immedica was founded in 2018 and employs today around 140 people across Europe, the Middle East and the United States. Immedica is backed by the investment firms KKR and Impilo.

For more information visit www.immedica.com.

Immedica contact:
Linda Holmström
Head of Communication
[email protected]
+ 46 708 73 40 95